Evidence map›Paper›PMID 35865394›Full record

ArticleMediterranean journal of hematology and infectious diseases2022

An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor

Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Maria Ilaria Del Principe, Antonio Cristiano, Tiziana Ottone, Maria Cristina Rapanotti, Mariadomenica Divona, Serena Travaglini and 5 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Beatrice BorsellinoDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Arianna SaviDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Maria Rosaria PascaleDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Elisa MeddiDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Maria Ilaria Del PrincipeDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Antonio CristianoDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Tiziana OttoneDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Maria Cristina RapanottiDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Mariadomenica DivonaDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Serena TravagliniDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Enrico AttardiDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Raffaele PalmieriDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Elisa BuzzattiDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Francesco BuccisanoDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Maria Teresa VosoDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
University of Rome Tor Vergata · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITMarche Polytechnic University · ITSaint Camillus International University of Health and Medical Sciences · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evolution of myeloproliferative neoplasms (MPN) to acute myeloid leukemia (AML) occurs in 2-10% of patients, depending on the MPN subtype, treatment, and follow-up length. The reverse-path from AML to MPN has been rarely reported. We herein present a 75 years old woman with AML, in whom a

Indexed as

Acute myeloid leukemiaJAK2 -V617FNGSPolycythemia veraTET2

Identifiers

PMID35865394
PMCPMC9266701
OpenAlexW4283709594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.